Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Tango Therapeutics, Inc.
Verastem, Inc.
GlaxoSmithKline
Region of Southern Denmark
National Cancer Institute (NCI)
Sun Yat-sen University
National Cancer Institute (NCI)
Novartis
Novartis
Servier
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Sensome
Sun Yat-sen University
Weill Medical College of Cornell University
University of Arizona
Roswell Park Cancer Institute
Novartis
Amgen
Eli Lilly and Company
Samsung Medical Center
Pfizer
Hoffmann-La Roche
Eli Lilly and Company
Pfizer
National Cancer Institute (NCI)
Pfizer
Integro Theranostics
Pfizer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
SWOG Cancer Research Network
Rutgers, The State University of New Jersey
Merck Sharp & Dohme LLC
Pheon Therapeutics
University of British Columbia
Dana-Farber Cancer Institute
M.D. Anderson Cancer Center
Eli Lilly and Company
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Teclison Ltd.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center